WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'4701 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 10'2041 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 10'277  10'148  10'017  9'884  9'750  8'663  7'245  5'826 
Births 218  219  219  220  220  217  217  200 
Surviving infants 212  213  213  214  214  208  205  184 
Pop. less than 5 years 1'063  1'065  1'068  1'070  1'072  1'027  998  883 
Pop. less than 15 years 3'134  3'127  3'123  3'115  3'110  3'027  2'791  2'480 
Female 15-49 years 2'688  2'659  2'627  2'594  2'559  2'244  1'792  1'366 

Number of reported case

(Click for retrospective incidence data for Dominican Republic (the))
Diphtheria 52  27  187 
Japanese encephalitis
Measles 254  3'477  9'760 
Mumps 2'760 
Pertussis 11  37  18  11  40  227  558 
Polio* 11  148 
Rubella 818 
Rubella (CRS)
Tetanus (neonatal) 12  14 
Tetanus (total) 40  45  50  59  66  25  56  113 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominican Republic (the))
Vaccine year result method % card seen                                                
BCG 2009  94  MICS     100  99*  98  96  92  90  68  29 
DTP1 2009  90  MICS     93  91  96  85  90 
DTP3 2009  64  MICS     85  84  88  82  85  78  69  36 
HepB_BD          74  82  80  73  69 
HepB3 2005  74  DHS   62.0  74  80  84  85  88  68 
Hib3 2005  74  DHS   62.0  70  71  81  77  79 
JapEnc         
MCV 2009  72  MICS     88  88  87  90  95  88  96  30 
MCV2         
PCV1          33 
PCV3         
Pol3 2009  65  MICS     85  84  86  85  87  67  90  46 
Rota1          59 
Rota_last          21 
Rubella1          88  88  87  90  95 
TT2plus 2001  86  DHS   50.3  90  63  13  63  25 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominican Republic (the))
BCG 99  99  98  96  92  90  70  29 
DTP1 92  91  96  85  90  91  87  61 
DTP3 85  84  88  82  85  78  69  36 
HepB3 74  80  84  85  88  68 
Hib3 70  71  81  77  79 
MCV 79  79  79  79  79  85  70  30 
PAB 90  90  87  86  86  48  60  23 
PCV3
Pol3 85  84  86  85  87  74  90  46 
Rota_last 20 

Number of districts in the country 155  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 37
From 80 to 89% 11
From 50 to 79% 45
Less than 50% 6
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes and risk groups at contact, +1, +6 months
Influenza 6 months; ; and risk groups and PW
MMR 12 months; Yes
MR In case of MMR stock outs
MenAC Special groups
MenACW Special groups
OPV 2, 4, 6, 18 months; 5 years; Yes
Pneumo_conj Yes From August 2013
Rotavirus Yes
Td 10, 20, 30, 40, 50, 60 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2010-2015  2006-2010  2006-2010  2006-2010  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number     75      26   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No    No         

System performance

Total number of districts in country number 155  155  155  155  155    158 
Nº districts with DTP3 coverage >=80% number 75  68  93  65  67  82  69 
% of districts with DTP3 coverage >=80% From 0 to 100% 48  44  60  42  43    44 
Nº districts with measles (MCV1) coverage >=95% number 46  47  38  42  42     
% of districts with MCV1 coverage >=95% From 0 to 100% 30  30  25  27  27     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  No  No    Yes    Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  50  100  90  90  94  69 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.